Microenvironment in HL and its relevance in response to therapy


E-session 637

Expert
Margaret A. Shipp'
Dana-Farber Cancer Institute
Boston, MA, USA
Discussant
Astrid Pavlovsky'
Clinical Research Center - FUNDALEU
Buenos Aires, Argentina

This e-Session is part of the following pathway(s):
27
Oct 2022